Evidence map›Paper›PMID 42239830›Full record

ArticleThe mental health clinician2026

Hyperammonemia associated with low doses and concentrations of valproic acid in older adults with neurocognitive disorder.

Sunni Coyne, Aparna Das

Abstract readCase Reports
In one paragraph

Article in The mental health clinician, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sunni CoynePsychiatry resident, Department of Psychiatry, Allegheny Health Network, Pittsburgh, Pennsylvania.ORCID https://orcid.org/0009-0005-1862-7770
Aparna Das(Corresponding author) Attending psychiatrist, Department of Psychiatry, Emory University School of Medicine, Atlanta, Georgia, aparna.das@emory.edu.ORCID https://orcid.org/0000-0002-9173-1858

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperammonemia is an idiosyncratic adverse effect associated with valproic acid (VPA). We report 2 patients with neurocognitive disorder who were prescribed low doses of VPA for neuropsychiatric symptoms associated with neurocognitive disorder, and they presented with changes in behavior. On workup, both patients had elevated ammonia concentrations. The aims of the case report are to highlight the importance of laboratory testing for ammonia concentrations in patients with altered mental status especially in the setting of VPA therapy irrespective of the dosage and to discuss possible mechanisms associated with VPA-induced hyperammonemia.

Indexed as

hyperammonemialaboratory testingvalproic acid

Identifiers

PMID42239830
PMCPMC13229526

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.